Symbol
| PHGDH
| contributors: mct - updated : 18-06-2016
|
HGNC name
| phosphoglycerate dehydrogenase
|
HGNC id
| 8923
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in leukemia, lymphoma and carcinoma | constitutional
|  
|  
| --other
|  
|
in cycling endometrial tissue, is relatively high in the proliferative phase in glandular cells and lower in the secretory phase | constitutional
|  
| deletion
|  
|  
|
L-serine deficiency caused by its deletion leads to robust induction of EIF4EBP1 and subsequent repression of translation initiation in the developing central nervous system | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
| | | |
| impaired neurogenesis in embryonic spinal cord of Phgdh knockout mice, a serine deficiency disorder model | |
severe impairment in neurogenesis of the central nervous system of Phgdh knockout (KO) embryos and a reduction in the protein content of their brains |